Wing-Yen Wong

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

Leonard A. Valentino, Vasily Mamonov, Andrzej Hellmann et al. · Journal of Thrombosis and Haemostasis · 2011 · 255 citations · Full text

Pharmacy, Hematology, Pharmacotherapy +5

Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination

Thomas V. Adamkiewicz, Sharada A. Sarnaik, George R. Buchanan et al. · The Journal of Pediatrics · 2003 · 142 citations

Medicine, Infectious Diseases, Pediatrics +17

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Pier Mannuccio Mannucci, Christine L. Kempton, Carolyn M. Millar et al. · Blood · 2013 · 129 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +9

Randomized comparison of prophylaxis and on‐demand regimens with <scp>FEIBA NF</scp> in the treatment of haemophilia A and B with inhibitors

Sandra Vallin Antunes, Srilatha Tangada, Oleksandra Stasyshyn et al. · Haemophilia · 2013 · 115 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Pharmacokinetics, efficacy and safety of BAX326, a novel recombinant factor IX: a prospective, controlled, multicentre phase I/III study in previously treated patients with severe (FIX level &lt;1%) or moderately severe (FIX level ≤2%) haemophilia B

Jerzy Windyga, Toshko Lissitchkov, Oleksandra Stasyshyn et al. · Haemophilia · 2013 · 48 citations

Medicine, Hematology, Pharmacokinetics +13